PGF(2α) facilitates pathological retinal angiogenesis by modulating endothelial FOS‐driven ELR (+) CXC chemokine expression

The pathological retinal angiogenesis often causes blindness. Current anti‐angiogenic therapy for proliferative retinopathy targets the vascular endothelial growth factor (VEGF), but many patients do not radically benefit from this therapy. Herein, we report that circulating prostaglandin (PG) F(2α)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yan, Lei, Yi, Ning, Huying, Zhang, Yaqiang, Chen, Guilin, Wang, Chenchen, Wan, Qiangyou, Guo, Shumin, Liu, Qian, Xie, Ruotian, Zhuo, Yujuan, Yan, Shuai, Zhao, Jing, Wei, Fengjiang, Wang, Lu, Wang, Xiaohong, Li, Weidong, Yan, Hua, Yu, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832840/
https://www.ncbi.nlm.nih.gov/pubmed/36511116
http://dx.doi.org/10.15252/emmm.202216373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832840/
https://www.ncbi.nlm.nih.gov/pubmed/36511116
http://dx.doi.org/10.15252/emmm.202216373

Ejemplares similares